Navigation Links
Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
Date:1/26/2012

TARRYTOWN, N.Y., Jan. 26, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2011 financial and operating results on Thursday, February 16, 2012, before the U.S. financial markets open.  The Company will host a conference call at 8:30 AM EST that day.

Live audio of the conference call will be webcast online simultaneously.  A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com.  A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.  

Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products, ARCALYST® (rilonacept) Injection For Subcutaneous Use and EYLEA™ (aflibercept) Injection.  Regeneron also has completed several Phase 3 studies and is conducting an additional Phase 3 clinical trial for the product candidate ZALTRAP® (aflibercept) Concentrate for Intravenous Infusion.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:   

 Manisha Narasimhan, Ph.D.

Peter DworkinInvestor Relations

Corporate Communications914-847-5126

914.847.764Manish
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
2. Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
3. Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
4. Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
5. Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
6. Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
7. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
8. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
9. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
10. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
11. Regeneron Reports Second Quarter 2011 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 Molecular Profiles Ltd., a subsidiary ... and Maryland -based Xceleron have announced ... during clinical development that will be launched at AAPS ... This partnership extends Molecular Profiles, new ROADMAP ... earlier this month. The company also has complementary collaborations ...
(Date:10/30/2014)... , October 30, 2014 ... GG hilft beim Aufbau von Kuhmilchverträglichkeit     ... für Lebensmittelallergien bei Säuglingen und Kleinkindern. Der ... bei der Ernährung der Babys bzw. deren ... sich jedoch, dass sich bei einer beträchtlichen ...
(Date:10/30/2014)... 29, 2014 nebulizer is a medical device ... and cystic fibrosis) that converts liquid medication into mist ... the lungs of a patient when inhaled through the ... is dominated by various devices powered by electric current ... asthma, COPD and cystic fibrosis and growing number of ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 3
... ... (commonly referred to as heart disease) is the leading cause of death for ... heart disease. Despite the prevalence of heart disease in women, a 2005 American ... cardiologists were not aware of the fact that more women than men die ...
... WESTFORD, Mass. , Feb. 9 LightLab Imaging, ... Tomography (OCT) for coronary artery applications, today reported that Trial ... for the commencement of the next phase of an ... Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc. ...
Cached Medicine Technology:Awareness of Heart Disease in Women Remains Low 2Awareness of Heart Disease in Women Remains Low 3Awareness of Heart Disease in Women Remains Low 4Awareness of Heart Disease in Women Remains Low 5Awareness of Heart Disease in Women Remains Low 6Awareness of Heart Disease in Women Remains Low 7Date Set for LightLab Damages Trial Against Volcano and Axsun 2
(Date:10/30/2014)... 2014 PreDiabetes Centers , the ... shoppers with a supply of sugardown®, a chewable ... post-meal blood sugar spikes. Learning how to control blood ... part of a diabetes prevention plan. , Shoppers who ... complimentary tube of sugardown. The offer expires November 30. ...
(Date:10/30/2014)... Radio listeners who indicate use of ... impact of traditional radio commercials and have overwhelmingly endorsed ... influence a purchasing decision. , Those are some highlights ... by radio marketing company CRN International. The research is ... of respondents who indicated they have purchased or considered ...
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Home Care ... leading provider of non-medical, in-home senior care, is weighing ... increased brain health. , The study, performed by the ... of 60 and 78 over a week-long period and ... to daily physical activity. By examining the structural soundness ...
(Date:10/30/2014)... FL (PRWEB) October 30, 2014 ... offering therapeutic horseback riding to special needs individuals in ... Round-Up on Saturday, November 15 from 10-2:00 p.m. at ... event is open to the public and is designed ... , Admission to the HSS Round-Up is free. ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2
... loss surgery has more benefits that simply reducing the fat. ... the McGill University// . ,The researchers studied ... study followed these people from 1986 to 2002. All patients ... with 5,700 people who did not undergo such surgery. ...
... at improving women's health researchers are facing a major ... participation in food trials and studies. ,Food ... lack of available women's research at this week's Institute ... world's largest annual meeting on food science, business and ...
... the June 26 issue of Archives of Internal Medicine, which ... have severe hot flashes// may have more chronic sleep problems ... that almost 85% of women in menopause experience hot flashes, ... It was explained that hot flashes often occur during the ...
... researchers at the University of Central Florida and University of ... space and how it affects the astronauts' health. ... aboard the Space Shuttle Discovery. The flies will need ... is scheduled to launch Saturday, July 1, from Kennedy Space ...
... down the catwalk alongside eight blind girl students at a ... are on for the show 'Light Up the World' slated ... Guwahati. Young fashion designer Himangshu Bora is busy training the ... have supermodels Nina Manuel and Dippanita Sharma for company that ...
... announced on Wednesday that as many as three million ... Southern Africa. //WFP executive director James Morris said that ... a distribution problem. ,"Good harvests do not ... "Food and good nutrition are crucial in battling against ...
Cached Medicine News:Health News:Women Doubtful of Food Research Benefiting Them 2Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Effect of Prolonged Stay in Space Studied Using Fruit Flies 2Health News:Effect of Prolonged Stay in Space Studied Using Fruit Flies 3Health News:Blind Girl Students to Catwalk in Guwahati Fashion Show 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: